돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 21175생성일: 2026년 10월 25일

Triethylamine → 4-(1,2-Dimethylimidazol-4-ylsulfonyloxy)-7-[1-(tert-butoxycarbonyl)-5-(piperidinomethyl)indol-2-yl]isoindolinone

https://huagongshe.com/reaction/21175

반응식

참여 물질

역할이름HCID투입량
반응물TriethylamineHCID 8471—
반응물1,2-Dimethylimidazole-4-sulfonyl chlorideHCID 2736256—
반응물4-Hydroxy-7-[1-(tert-butoxycarbonyl)-5-(piperidinomethyl)indol-2-yl]isoindolinoneHCID 68493222—
용매AcetonitrileHCID 6342—
생성물4-(1,2-Dimethylimidazol-4-ylsulfonyloxy)-7-[1-(tert-butoxycarbonyl)-5-(piperidinomethyl)indol-2-yl]isoindolinoneHCID 8662827851.1%

반응 단계

In a similar manner to Step 1 of Example 233, 4-hydroxy-7-[1-(tert-butoxycarbonyl)-5-(piperidinomethyl)indol-2-yl]isoindolinone (0.0316 g, 0.0685 mmol) was dissolved in acetonitrile (0.650 mL), and the solution was treated with triethylamine (0.0570 mL, 0.411 mmol) and 1,2-dimethylimidazole-4-sulfonyl chloride (0.0400 mL, 0.205 mmol) to obtain 4-(1,2-dimethylimidazol-4-ylsulfonyloxy)-7-[1-(tert-butoxycarbonyl)-5-(piperidinomethyl)indol-2-yl]isoindolinone (0.0217 g, yield 51%).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07745641B2
출처 데이터셋uspto-grants-2010_06
ORD IDord-feb6fc654c514f94b9692f159cc19fae
출처 메모uspto-grants-2010_06